Sign Up to like & get
recommendations!
0
Published in 2020 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2020.02.171
Abstract: BACKGROUND Kidney transplant recipients (KTRs) are routinely excluded from direct oral anticoagulant (DOAC) trials. Given the lack of safety and efficacy data in this population, we examined real-world prescribing practices of DOACs in KTRs. METHODS…
read more here.
Keywords:
oral anticoagulant;
kidney transplant;
direct oral;
ontario canada ... See more keywords